A nurse is talking to a client who wants to stop taking glucocorticoids after taking them for 3 months. Which statement by the client indicates a good understanding of the teaching about withdrawal?

a) This is false because oral medications can be given to infants if they are in liquid form, have a suitable dose, and are administered with a dropper or syringe. However, oral medications should be given with caution and only when prescribed by a doctor.

b) This is false because lipid-soluble drugs are not easily passed into breast milk and do not affect breastfeeding infants. However, some drugs can be harmful to breastfeeding infants and should be avoided or used with caution by nursing mothers.

c) Immaturity of renal function in infancy affects drug excretion, potentially leading to prolonged drug effects and increased risk of toxicity.

d) Infants are more sensitive to medications that act on the central nervous system, and dose adjustments may be needed to prevent adverse effects.

e) Immature liver function in infants can slow down drug metabolism and elimination, leading to a higher risk of drug accumulation and toxicity.

A) This is not a risk of estrogen/progestin therapy. In fact, estrogen/progestin therapy can help prevent osteoporosis and fractures by increasing bone density and strength.

B) This is a possible risk of estrogen/progestin therapy. Some studies have suggested that taking estrogen/progestin therapy for more than five years may increase the risk of ovarian cancer. However, other studies have not found this association

C) This is a serious risk of estrogen/progestin therapy. Estrogen/progestin therapy can increase the risk of blood clots, which can lead to stroke or heart attack. The risk is higher for women who smoke, have high blood pressure, diabetes, or a history of cardiovascular disease.

D) This is not a risk of estrogen/progestin therapy. In fact, some studies have suggested that estrogen/progestin therapy may reduce the risk of colon cancer by lowering inflammation and promoting regular bowel movements.

E) This is another serious risk of estrogen/progestin therapy. Deep vein thrombosis (DVT) is a condition where a blood clot forms in a deep vein, usually in the leg. It can cause pain, swelling, and redness in the affected area. If the clot breaks off and travels to the lungs, it can cause a life threatening condition called pulmonary embolism (PE). Estrogen/progestin therapy can increase the risk of DVT and PE by making the blood more likely to clot